Novartis AG

Total cases

11 (3 active)

Claimant-side

Respondent-side

Novartis AG has been party to eleven Unified Patent Court cases, 4 times as claimant and 7 times as respondent. The most recent on record is UPC CFI 382/2025 at the Milan Central Division, against Zentiva, k.s.

Adversary analytics require an account

Recent cases

View all cases

2025-04-29UPC CFI 382/2025Milan CDCosts onlyNovartis AG v Zentiva, k.s.
2025-02-27UPC APP 10151/2025Milan CDProcedural onlyALIUD PHARMA GmbH v Accord Healthcare B.V.
2025-02-18UPC CoA 150/2025Court of AppealProcedural onlySTADAPHARM GmbH v Accord Healthcare B.V.
2024-12-30UPC APP 68658/2024Milan CDDismissedSTADAPHARM GmbH v Accord Healthcare B.V.
2024-11-14UPC APP 61187/2024Dusseldorf LD—COHAUSZ & FLORACK Patent- und Rechtsanwälte Partnerschaftsgesellschaft mbB v Novartis AG
2024-11-14UPC APP 61203/2024Dusseldorf LD—COHAUSZ & FLORACK Patent- und Rechtsanwälte Partnerschaftsgesellschaft mbB v Novartis AG
2024-11-14UPC CFI 698/2024Milan CDDismissedAccord Healthcare B.V. v Novartis AG
2024-04-09UPC CFI 165/2024Dusseldorf LDPI deniedNovartis AG v Celltrion Healthcare Hungary Kft.
2024-04-09UPC CFI 166/2024Dusseldorf LD—Novartis AG v Celltrion Inc.
—ACT 18551/2024Dusseldorf LDPI deniedNovartis AG v Celltrion Inc.